SOD1 and amyotrophic lateral sclerosis: The suggested protective effect of dyslipidemia on ALS survival [8], the reduced survival observed in SOD1‐mice treated with statins [20, 21], and reports of increased muscle cramps and functional decline among ALS patients using statins [22] have raised concerns about the safety of statins in ALS.